. Author manuscript; available in PMC: 2016 Nov 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2015 Jul 31;21(11):1985–1993. doi: 10.1016/j.bbmt.2015.07.029

Table 3.

Comparison of early and late causes of treatment failure after URDT and DCBT.

Events	8/8 URDT (28/ 66, 42%)	7/8 URDT (26/ 45, 58%)	DCBT (17/ 55, 31%)

	Before Day 180

TRM	5 (8%)	5 (11%)	12 (22%)
Graft Failure	-	-	2
GVHD	-	1	4
Organ Failure	1	-	4
Infection	4	3	2
Other^*	-	1	-

Relapse	1 (2%)	3 (7%)	1 (2%)

	After Day 180

TRM	9 (14%)	12 (27%)	1 (2%)
Graft Failure	-	1	-
GVHD	4	8	1
Organ Failure	1	-	-
Infection	2	3	-
Other^*	2	-	-

Relapse	13 (20%)	6 (13%)	3 (5%)

URDT indicates unrelated donor transplantation; DCBT, double-unit cord blood transplantation; TRM, transplant-related mortality; GVHD, graft-versus-host disease.

Other included one patient who died prior to day 180 of leukoencephalopathy of unknown etiology, one with recurrent breast cancer and one who died of secondary malignancy after day 180.